Snapshot · Russell 3000 · generated 2026-10-17 22:04 UTC
LGND — Ligand Pharmaceuticals Incorporated
EXPENSIVE (MOS -173.3%) · Quality 84/100
Price
295.54
Intrinsic value
108.14
Margin of safety
-173.3%
Implied growth (reverse DCF)
+58.6%
model assumes +15.5%
Value Score
22.1
Quality
84
Psychology
3.8
Discovery
8.7
price/volume attention only
Moat score
21
erosion: none
Value Score: bottom 37% of Russell 3000 · Quality: top 3%
Open the interactive Deep Dive for LGND →
Use this data programmatically
This page's numbers are also available as JSON at /api/v1/deep-dive/LGND - see the API docs for the full read-only surface, including an MCP server for AI assistants.
Common questions
Is LGND undervalued?
As of 2026-10-17, LGND trades at 295.54 against a computed intrinsic value of 108.14 (-173.3% margin of safety) - StocksDeepDive's valuation label for this is EXPENSIVE. This is a described calculation from public data, not a recommendation.
What is Ligand Pharmaceuticals Incorporated's Value Score?
Ligand Pharmaceuticals Incorporated's Value Score is 22.1 as of 2026-10-17 - it combines value, quality, crowd psychology and market attention into one number.